News for Rezolute, Inc. (RZLT)

We recently published an article titled 13 Best Multibagger Stocks to Invest in Now. Rezolute, Inc. (NASDAQ:RZLT) was one of the stocks that was covered in that article. Wall Street analysts believe RZLT has a 260% upside potential over the next 12 months. Rezolute, Inc. (NASDAQ:RZLT) is a late-stage biopharmaceutical company focused on addressing rare […]

sunRIZE enrollment on track including U.S. sites and expected to be completed in May 2025; topline data anticipated in December 2025 U.S. Food and Drug Adminis

Rezolute (RZLT) has achieved a significant milestone with the U.S. Food and Drug Administration granting Breakthrough Therapy Designation to its experimental tr

**media[614538]**

REDWOOD CITY, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Rezolute, Inc. ( RZLT) (”œRezolute” or the ”œCompany”), a late-stage rare disease company focused

Rezolute has done well to continue to advance its lead drug from its pipeline, ersodetug. Click here to see why RZLT stock is a Buy.

H.C. Wainwright expressed no surprise at the decision by the independent data monitoring committee to maintain the current course of Rezolute's (RZLT) sunRIZE t

Rezolute, Inc. (RZLT) successfully closed its underwritten offering, raising approximately $96.9 million in net proceeds. The offering included 24,940,7

**media[606007]**

Biopharmaceutical company Rezolute, Inc. (RZLT) has announced the pricing of an underwritten public offering, aligning with Nasdaq regulations. This includes 20

NEW YORK, April 23, 2025 (GLOBE NEWSWIRE) -- Rezolute, Inc. ( RZLT) (”œRezolute” or the ”œCompany”), a late-stage biopharmaceutical company committed to

Rezolute, Inc. (RZLT) is moving forward with its Phase 3 sunRIZE clinical trial as planned, following positive feedback from the Data Monitoring Committee (DMC)

California-based Ensysce Biosciences, Inc. (ENSC) is up over 133 percent in Wednesday's pre-market trading. The following are some of the other stocks making big moves in Wednesday's pre-market trading.

California-based Ensysce Biosciences, Inc. (ENSC) is up over 133 percent in Wednesday's pre-market trading. The following are some of the other stocks making big moves in Wednesday's pre-market trading.

Rezolute, Inc. (RZLT) prices $90 million offering, targeting significant capital infusion. Major participation from prominent investors like Blackstone

Independent Data Monitoring Committee (the ”œDMC”) recommends continuation of sunRIZE trial as planned with no need to increase sample size Enrollment on tr

Shares of The AZEK Company Inc. AZEK rose sharply in today's pre-market trading after James Hardie Industries plc JHX announced plans to acquire the company for...

**media[568943]**

Rezolute (RZLT) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.